Chemoradiotherapy-Associated Myelosuppression: A Retrospective Analysis of Risk Factors for Patients with Non-Small Cell Lung Cancer

Creative Commons License

Yilmaz U. M., EROL S., Yalcin B., Anar C., Ozdogan Y., Gurlek U., ...Daha Fazla

EURASIAN JOURNAL OF PULMONOLOGY, cilt.17, sa.1, ss.49-53, 2015 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5152/ejp.2015.87487
  • Dergi Adı: EURASIAN JOURNAL OF PULMONOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.49-53
  • Anahtar Kelimeler: Chemoradiotherapy, lung cancer, neutropenia, risk factors, CHEMOTHERAPY, CISPLATIN, ONCOLOGY, RADIATION, ETOPOSIDE
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Concomitant chemoradiotherapy (CRT) is the standard treatment for patients with stage III non-small cell lung cancer (NSCLC). Myelosuppression can be a significant problem in concomitant CRT. The aim of this study was to assess the parameters obtained before concomitant CRT to define the risk factors for myelosuppression in patients with locally advanced NSCLC.